Shares of HCA Healthcare Inc (NYSE:HCA) have earned an average rating of “Buy” from the twenty-seven brokerages that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have assigned a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $88.67.
Several equities analysts recently weighed in on the stock. Piper Jaffray Companies lowered shares of HCA Healthcare from an “overweight” rating to a “neutral” rating and set a $81.00 price target for the company. in a research report on Wednesday, January 3rd. Robert W. Baird set a $104.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Friday. Goldman Sachs Group assumed coverage on shares of HCA Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating for the company. Argus set a $97.00 price target on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday. Finally, ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd.
In other news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the transaction, the insider now directly owns 12,476 shares in the company, valued at $973,128. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Victor L. Campbell sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at $9,649,990.50. The disclosure for this sale can be found here. Insiders have sold 22,700 shares of company stock valued at $1,773,872 in the last quarter. Company insiders own 2.90% of the company’s stock.
HCA Healthcare (NYSE:HCA) traded up $2.01 on Friday, reaching $86.97. 1,911,000 shares of the company traded hands, compared to its average volume of 2,114,988. The company has a market capitalization of $31,420.00, a price-to-earnings ratio of 12.37, a P/E/G ratio of 1.17 and a beta of 0.55. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. HCA Healthcare has a one year low of $71.18 and a one year high of $91.03.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.21. The company had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 earnings per share. equities analysts predict that HCA Healthcare will post 6.56 EPS for the current year.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.